Chromocell Therapeutics (CHRO) Stock Chart & Stock Price History $0.99 -0.04 (-3.88%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.99 0.00 (0.00%) As of 07:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock Chromocell Therapeutics Stock Price Performance The Chromocell Therapeutics (CHRO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.36%, with a year-to-date return of 54.45%. In the past month, the stock has decreased 36.13%, reflecting recent market activity. As of the latest close, Chromocell Therapeutics traded at $0.99 with a market cap of $6.53 million and volume of 18,964 shares. Receive CHRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.00%1 Month Performance-36.13%3 Month Performance-41.07%Year-To-Date Performance+54.45%1 Year Performance-40.36% CHRO Stock Chart for Thursday, May, 22, 2025 CHRO Chart by TradingView Chromocell Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$1.03$0.99-3.88%$1.03$0.9718,964 shs$6.53 million05/20/2025$1.05$1.03-1.90%$1.06$0.9717,617 shs$6.79 million05/19/2025$1.00$1.05+5.00%$1.12$0.9652,430 shs$6.45 million05/16/2025$0.96$1.00+4.17%$1.05$0.9735,605 shs$6.14 million05/15/2025$1.06$0.96-9.43%$1.02$0.92187,013 shs$5.86 million05/14/2025$1.07$1.06-0.93%$1.10$0.91728,638 shs$6.47 million05/13/2025$1.08$1.07-0.83%$1.14$1.03109,937 shs$6.53 million05/12/2025$1.10$1.08-1.91%$1.09$0.95159,231 shs$6.59 million05/09/2025$1.12$1.10-1.79%$1.13$1.0233,618 shs$6.71 million05/08/2025$1.09$1.12+2.75%$1.15$1.0962,335 shs$6.84 million Get the Latest News and Ratings for CHRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$1.12$1.09-2.68%$1.16$1.0530,094 shs$6.65 million05/06/2025$1.19$1.12-5.88%$1.20$1.1129,515 shs$6.84 million05/05/2025$1.26$1.19-5.56%$1.29$1.1832,353 shs$7.26 million05/02/2025$1.25$1.26+0.80%$1.31$1.1762,937 shs$7.69 million05/01/2025$1.14$1.25+9.65%$1.28$1.0670,638 shs$7.63 million04/30/2025$1.28$1.14-10.94%$1.23$1.1431,172 shs$6.96 million04/29/2025$1.35$1.28-5.19%$1.38$1.1862,775 shs$7.81 million04/28/2025$1.36$1.35-0.74%$1.37$1.2743,524 shs$8.24 million04/25/2025$1.39$1.36-1.81%$1.36$1.2668,644 shs$8.30 million04/24/2025$1.37$1.39+1.09%$1.53$1.25170,796 shs$8.45 million04/23/2025$1.55$1.37-11.61%$1.65$1.37115,549 shs$8.36 million04/22/2025$1.43$1.55+8.39%$1.58$1.32270,832 shs$9.46 million04/21/2025$1.84$1.43-22.28%$1.90$1.29818,164 shs$8.73 million Related Companies Cadrenal Therapeutics Stock Chart Daré Bioscience Stock Chart Generation Bio Stock Chart Surrozen Stock Chart CytoMed Therapeutics Stock Chart OnKure Therapeutics Stock Chart ALX Oncology Stock Chart ABVC BioPharma Stock Chart BioAtla Stock Chart Eagle Pharmaceuticals Stock Chart Receive CHRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CHRO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chromocell Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chromocell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
